1
|
Mladenović M, Astolfi R, Tomašević N, Matić S, Božović M, Sapienza F, Ragno R. In Vitro Antioxidant and In Vivo Antigenotoxic Features of a Series of 61 Essential Oils and Quantitative Composition-Activity Relationships Modeled through Machine Learning Algorithms. Antioxidants (Basel) 2023; 12:1815. [PMID: 37891894 PMCID: PMC10604248 DOI: 10.3390/antiox12101815] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/24/2023] [Revised: 09/25/2023] [Accepted: 09/26/2023] [Indexed: 10/29/2023] Open
Abstract
The antioxidant activity of essential oils (EOs) is an important and frequently studied property, yet it is not sufficiently understood in terms of the contribution of EOs mixtures' constituents and biological properties. In this study, a series of 61 commercial EOs were first evaluated as antioxidants in vitro, following as closely as possible the cellular pathways of reactive oxygen species (ROS) generation. Hence, EOs were assessed for the ability either to chelate metal ions, thus interfering with ROS generation within the respiratory chain, or to neutralize 2,2-diphenyl-1-picrylhydrazyl (DPPH•) and lipid peroxide radicals (LOO•), thereby halting lipid peroxidation, as well as to neutralize 2,2'-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid cation radicals (ABTS•+) and hydroxyl radicals (OH•), thereby preventing the ROS species from damaging DNA nucleotides. Showing noteworthy potencies to neutralize all of the radicals at the ng/mL level, the active EOs were also characterized as protectors of DNA double strands from damage induced by peroxyl radicals (ROO•), emerging from 2,2'-azobis-2-methyl-propanimidamide (AAPH) as a source, and OH•, indicating some genome protectivity and antigenotoxicity effectiveness in vitro. The chemical compositions of the EOs associated with the obtained activities were then analyzed by means of machine learning (ML) classification algorithms to generate quantitative composition-activity relationships (QCARs) models (models published in the AI4EssOil database available online). The QCARs models enabled us to highlight the key features (EOSs' chemical compounds) for exerting the redox potencies and to define the partial dependencies of the features, viz. percentages in the mixture required to exert a given potency. The ML-based models explained either the positive or negative contribution of the most important chemical components: limonene, linalool, carvacrol, eucalyptol, α-pinene, thymol, caryophyllene, p-cymene, eugenol, and chrysanthone. Finally, the most potent EOs in vitro, Ylang-ylang (Cananga odorata (Lam.)) and Ceylon cinnamon peel (Cinnamomum verum J. Presl), were promptly administered in vivo to evaluate the rescue ability against redox damage caused by CCl4, thereby verifying their antioxidant and antigenotoxic properties either in the liver or in the kidney.
Collapse
Affiliation(s)
- Milan Mladenović
- Kragujevac Center for Computational Biochemistry, Department of Chemistry, Faculty of Science, University of Kragujevac, Radoja Domanovića 12, P.O. Box 60, 34000 Kragujevac, Serbia;
| | - Roberta Astolfi
- Rome Center for Molecular Design, Department of Drug Chemistry and Technology, Faculty of Pharmacy and Medicine, Rome Sapienza University, P. le A. Moro 5, 00185 Rome, Italy; (R.A.); (F.S.)
| | - Nevena Tomašević
- Kragujevac Center for Computational Biochemistry, Department of Chemistry, Faculty of Science, University of Kragujevac, Radoja Domanovića 12, P.O. Box 60, 34000 Kragujevac, Serbia;
| | - Sanja Matić
- Department of Science, Institute for Information Technologies Kragujevac, University of Kragujevac, Jovana Cvijića bb, 34000 Kragujevac, Serbia;
| | - Mijat Božović
- Faculty of Science and Mathematics, University of Montenegro, Džordža Vašingtona bb, 81000 Podgorica, Montenegro;
| | - Filippo Sapienza
- Rome Center for Molecular Design, Department of Drug Chemistry and Technology, Faculty of Pharmacy and Medicine, Rome Sapienza University, P. le A. Moro 5, 00185 Rome, Italy; (R.A.); (F.S.)
| | - Rino Ragno
- Rome Center for Molecular Design, Department of Drug Chemistry and Technology, Faculty of Pharmacy and Medicine, Rome Sapienza University, P. le A. Moro 5, 00185 Rome, Italy; (R.A.); (F.S.)
| |
Collapse
|
2
|
Baldisserotto A, Baldini E, Ravarotto S, Cesa E, De Lucia D, Durini E, Vertuani S, Manfredini S, Michniak-Kohn BB. Expert Systems for Predicting the Bioavailability of Sun Filters in Cosmetic Products, Software vs. Expert Formulator: The Benzophenone-3 Case. Pharmaceutics 2022; 14:pharmaceutics14091815. [PMID: 36145564 PMCID: PMC9500902 DOI: 10.3390/pharmaceutics14091815] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/07/2022] [Revised: 08/18/2022] [Accepted: 08/21/2022] [Indexed: 11/30/2022] Open
Abstract
There are only a limited number of molecules in a cosmetic formulation, which can passively cross the stratum corneum and be absorbed into the skin layers. However, some actives should never cross the skin in large concentrations due to their potential for side effects, for example, sunscreens. Artificial intelligence is gaining an increasing role as a predictive tool, and in this regard, we selected the Formulating for Efficacy® Software to forecast the changes in bioavailability of selected topical cosmetic compounds. Using the Franz diffusion cell methodology, various oils were selected as those with low release capability, and these were compared to those suggested by the software in Benzophenone-3-containing formulations. The software was able to predict the lipophilic phases, which, if utilized in the emulsion, were stable and sometimes even more pleasant in appearance and consistency than the reference emulsions prepared by the formulator. To date, however, Formulating for Efficacy® Software still has limitations as far as predicting the hydrophilic phase, as well as not being able to choose the emulsifier or the preservative system.
Collapse
Affiliation(s)
- Anna Baldisserotto
- Department of Life Sciences and Biotechnology, Section of Medicinal and Health Products, University of Ferrara, Via Fossato di Mortara 17-19, 44121 Ferrara, Italy
| | - Erika Baldini
- Department of Life Sciences and Biotechnology, Section of Medicinal and Health Products, University of Ferrara, Via Fossato di Mortara 17-19, 44121 Ferrara, Italy
- Department of Life Sciences and Biotechnology, University of Ferrara, Via Fossato di Mortara 17-19, 44124 Ferrara, Italy
| | - Sara Ravarotto
- Department of Life Sciences and Biotechnology, University of Ferrara, Via Fossato di Mortara 17-19, 44124 Ferrara, Italy
| | - Elena Cesa
- Department of Life Sciences and Biotechnology, Section of Medicinal and Health Products, University of Ferrara, Via Fossato di Mortara 17-19, 44121 Ferrara, Italy
| | - Daniela De Lucia
- DLD Scientific LLC, United State Corporation Agent, Inc., Pine Brook, NJ 07058, USA
| | - Elisa Durini
- Department of Life Sciences and Biotechnology, Section of Medicinal and Health Products, University of Ferrara, Via Fossato di Mortara 17-19, 44121 Ferrara, Italy
- Department of Life Sciences and Biotechnology, University of Ferrara, Via Fossato di Mortara 17-19, 44124 Ferrara, Italy
| | - Silvia Vertuani
- Department of Life Sciences and Biotechnology, Section of Medicinal and Health Products, University of Ferrara, Via Fossato di Mortara 17-19, 44121 Ferrara, Italy
- Department of Life Sciences and Biotechnology, University of Ferrara, Via Fossato di Mortara 17-19, 44124 Ferrara, Italy
- Correspondence: (S.V.); (S.M.); Tel.: +39-0532-455294 (S.M.)
| | - Stefano Manfredini
- Department of Life Sciences and Biotechnology, Section of Medicinal and Health Products, University of Ferrara, Via Fossato di Mortara 17-19, 44121 Ferrara, Italy
- Department of Life Sciences and Biotechnology, University of Ferrara, Via Fossato di Mortara 17-19, 44124 Ferrara, Italy
- Correspondence: (S.V.); (S.M.); Tel.: +39-0532-455294 (S.M.)
| | - Bozena B. Michniak-Kohn
- Center for Dermal Research (CDR) & Laboratory for Drug Delivery (LDD) Life Sciences Building, Rutgers—The State University of New Jersey, 145 Bevier Road, Piscataway, NJ 08854, USA
| |
Collapse
|
3
|
Artini M, Papa R, Sapienza F, Božović M, Vrenna G, Tuccio Guarna Assanti V, Sabatino M, Garzoli S, Fiscarelli EV, Ragno R, Selan L. Essential Oils Biofilm Modulation Activity and Machine Learning Analysis on Pseudomonas aeruginosa Isolates from Cystic Fibrosis Patients. Microorganisms 2022; 10:microorganisms10050887. [PMID: 35630332 PMCID: PMC9145053 DOI: 10.3390/microorganisms10050887] [Citation(s) in RCA: 11] [Impact Index Per Article: 5.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/31/2022] [Revised: 04/21/2022] [Accepted: 04/22/2022] [Indexed: 02/01/2023] Open
Abstract
The opportunistic pathogen Pseudomonas aeruginosa is often involved in airway infections of cystic fibrosis (CF) patients. It persists in the hostile CF lung environment, inducing chronic infections due to the production of several virulence factors. In this regard, the ability to form a biofilm plays a pivotal role in CF airway colonization by P. aeruginosa. Bacterial virulence mitigation and bacterial cell adhesion hampering and/or biofilm reduced formation could represent a major target for the development of new therapeutic treatments for infection control. Essential oils (EOs) are being considered as a potential alternative in clinical settings for the prevention, treatment, and control of infections sustained by microbial biofilms. EOs are complex mixtures of different classes of organic compounds, usually used for the treatment of upper respiratory tract infections in traditional medicine. Recently, a wide series of EOs were investigated for their ability to modulate biofilm production by different pathogens comprising S. aureus, S. epidermidis, and P. aeruginosa strains. Machine learning (ML) algorithms were applied to develop classification models in order to suggest a possible antibiofilm action for each chemical component of the studied EOs. In the present study, we assessed the biofilm growth modulation exerted by 61 commercial EOs on a selected number of P. aeruginosa strains isolated from CF patients. Furthermore, ML has been used to shed light on the EO chemical components likely responsible for the positive or negative modulation of bacterial biofilm formation.
Collapse
Affiliation(s)
- Marco Artini
- Department of Public Health and Infectious Diseases, Sapienza University, p.le Aldo Moro 5, 00185 Rome, Italy; (M.A.); (R.P.); (G.V.)
| | - Rosanna Papa
- Department of Public Health and Infectious Diseases, Sapienza University, p.le Aldo Moro 5, 00185 Rome, Italy; (M.A.); (R.P.); (G.V.)
| | - Filippo Sapienza
- Rome Center for Molecular Design, Department of Drug Chemistry and Technology, Sapienza University, p.le Aldo Moro 5, 00185 Rome, Italy; (F.S.); (M.S.)
- Department of Drug Chemistry and Technology, Sapienza University, p.le Aldo Moro 5, 00185 Rome, Italy;
| | - Mijat Božović
- Faculty of Natural Sciences and Mathematics, University of Montenegro, Džordža Vašingtona bb, 81000 Podgorica, Montenegro;
| | - Gianluca Vrenna
- Department of Public Health and Infectious Diseases, Sapienza University, p.le Aldo Moro 5, 00185 Rome, Italy; (M.A.); (R.P.); (G.V.)
| | - Vanessa Tuccio Guarna Assanti
- Research Unit of Diagnostical and Management Innovations, Children’s Hospital and Institute Research Bambino Gesù, 00165 Rome, Italy; (V.T.G.A.); (E.V.F.)
| | - Manuela Sabatino
- Rome Center for Molecular Design, Department of Drug Chemistry and Technology, Sapienza University, p.le Aldo Moro 5, 00185 Rome, Italy; (F.S.); (M.S.)
- Department of Drug Chemistry and Technology, Sapienza University, p.le Aldo Moro 5, 00185 Rome, Italy;
| | - Stefania Garzoli
- Department of Drug Chemistry and Technology, Sapienza University, p.le Aldo Moro 5, 00185 Rome, Italy;
| | - Ersilia Vita Fiscarelli
- Research Unit of Diagnostical and Management Innovations, Children’s Hospital and Institute Research Bambino Gesù, 00165 Rome, Italy; (V.T.G.A.); (E.V.F.)
| | - Rino Ragno
- Rome Center for Molecular Design, Department of Drug Chemistry and Technology, Sapienza University, p.le Aldo Moro 5, 00185 Rome, Italy; (F.S.); (M.S.)
- Department of Drug Chemistry and Technology, Sapienza University, p.le Aldo Moro 5, 00185 Rome, Italy;
- Società Italiana Ricerca Oli Essenziali, Viale Regina Elena 299, 00161 Roma, Italy
- Correspondence: (R.R.); (L.S.)
| | - Laura Selan
- Department of Public Health and Infectious Diseases, Sapienza University, p.le Aldo Moro 5, 00185 Rome, Italy; (M.A.); (R.P.); (G.V.)
- Correspondence: (R.R.); (L.S.)
| |
Collapse
|